Literature DB >> 18655832

Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.

René J Duquesnoy1.   

Abstract

HLAMatchmaker is a computer algorithm that determines HLA compatibility at the structural level. Donor-recipient histocompatibility is assessed with polymorphic amino acid configurations that represent structurally defined elements of HLA epitopes originally assigned as triplets and more recently as eplets. For many patients, HLAMatchmaker can identify mismatched HLA antigens that can be considered compatible at the structural level. Structurally based HLA matching reduces humoral allosensitization and correlates with good transplant outcome. Moreover, HLAMatchmaker is useful in the analysis of serum antibody reactivity and benefits the strategy of identifying acceptable mismatches for highly sensitized patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655832     DOI: 10.1016/j.coi.2008.06.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

Review 1.  Concise review: mind the gap: challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation.

Authors:  Erin A Rayment; David J Williams
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

2.  HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome.

Authors:  Chen Yanover; Effie W Petersdorf; Mari Malkki; Ted Gooley; Stephen Spellman; Andrea Velardi; Peter Bardy; Alejandro Madrigal; Jean-Denis Bignon; Philip Bradley
Journal:  Immunome Res       Date:  2011

Review 3.  Predicting alloreactivity in transplantation.

Authors:  Kirsten Geneugelijk; Kirsten Anne Thus; Eric Spierings
Journal:  J Immunol Res       Date:  2014-04-28       Impact factor: 4.818

4.  Computational Approaches to Facilitate Epitope-Based HLA Matching in Solid Organ Transplantation.

Authors:  Kirsten Geneugelijk; Jeroen Wissing; Dirk Koppenaal; Matthias Niemann; Eric Spierings
Journal:  J Immunol Res       Date:  2017-02-12       Impact factor: 4.818

5.  Pre-transplant Compatibility Tests in Kidney Transplants: Case Report on Significance of Epitope-based Analysis in Donor Selection.

Authors:  Chhavi Rajvanshi; Aseem Kumar Tiwari; Jui Choudhuri; Simmi Mehra; Rajni Chauhan
Journal:  Indian J Nephrol       Date:  2019-09-06

Review 6.  Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.

Authors:  Anat R Tambur; Patricia Campbell; Anita S Chong; Sandy Feng; Mandy L Ford; Howard Gebel; Ronald G Gill; Garnett Kelsoe; Vasilis Kosmoliaptsis; Roslyn B Mannon; Michael Mengel; Elaine F Reed; Nicole M Valenzuela; Chris Wiebe; I Esme Dijke; Harold C Sullivan; Peter Nickerson
Journal:  Am J Transplant       Date:  2020-05-27       Impact factor: 8.086

7.  Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity.

Authors:  René J Duquesnoy
Journal:  Front Immunol       Date:  2011-11-08       Impact factor: 7.561

Review 8.  Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.

Authors:  Tilahun Alelign; Momina M Ahmed; Kidist Bobosha; Yewondwossen Tadesse; Rawleigh Howe; Beyene Petros
Journal:  J Immunol Res       Date:  2018-03-05       Impact factor: 4.818

Review 9.  PIRCHE-II: an algorithm to predict indirectly recognizable HLA epitopes in solid organ transplantation.

Authors:  Kirsten Geneugelijk; Eric Spierings
Journal:  Immunogenetics       Date:  2019-11-18       Impact factor: 2.846

10.  Applicability of an instrument to identify human leukocyte antigen-compatible donors for platelet transfusions.

Authors:  Millena Gomes Ferreira; Fernanda Bernadelli De Vito; Aline Aparecida Ferreira; Carolina Bonet Bub; Fernando Antônio Vinhal Dos Santos; Adilson Botelho Filho; Sheila Soares Silva; Helio Moraes-Souza
Journal:  Hematol Transfus Cell Ther       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.